Dalian Bio-Chem concludes 2023 employee stock ownership plan

Dalian Bio-Chem announced the successful completion and termination of its 2023 employee stock ownership plan. The second restricted period for the plan ended on October 16, 2025, with 5,075,932 shares unlocking. These shares, representing 0.72% of the company's total share capital, were transferred to the personal securities accounts of 83 participants on November 5, 2025.

The initial plan, approved in August and September 2023, saw 5,179,522 shares transferred to the plan's securities account on October 13, 2023. Following a 2023 annual profit distribution, the number of shares increased to 7,251,331. The first unlocking, which occurred on October 16, 2024, saw 3,625,665 shares transferred to participants' accounts. Subsequent to the 2024 annual profit distribution, the remaining shares increased to 5,075,932.

With the latest non-trade transfer, all shares held under the 2023 employee stock ownership plan have been disbursed, marking the plan's full implementation and termination. The company affirmed its adherence to market trading rules and regulations throughout the plan's duration.